Data window: July to 7 November 2026. Page published 7 November 2026. On 28 October 2026, the US Department of Health and Human Services (HHS) said it will not act against 503A pharmacies that compound six peptides (BPC-157, TB-500, MOTS-c, KPV, Semax and Epitalon) under strict conditions. This page compares that list with what people actually track in the Peptide Lab app. Every figure is a share of accounts that saved at least one vial, across several hundred accounts. No individual record is shown, no cell under 20 accounts is reported, and no dose figure is published.
📌 Journalists & writers: these figures are free to cite under CC BY 4.0. Suggested citation: Klow Peptide, "HHS Peptide Policy vs Real Use: What Tracker Data Shows," November 2026, https://klow-peptide.com/en/pages/hhs-peptide-policy-user-data/. Questions: [email protected].